Innoviva, Inc. Files 8-K with SEC

Ticker: INVA · Form: 8-K · Filed: May 13, 2024 · CIK: 1080014

Innoviva, INC. 8-K Filing Summary
FieldDetail
CompanyInnoviva, INC. (INVA)
Form Type8-K
Filed DateMay 13, 2024
Risk Levellow
Pages2
Reading Time2 min
Key Dollar Amounts$0.01
Sentimentneutral

Sentiment: neutral

Topics: sec-filing, 8-k, disclosure

TL;DR

Innoviva filed an 8-K. Check for updates.

AI Summary

Innoviva, Inc. filed an 8-K on May 13, 2024, reporting a Regulation FD Disclosure and Financial Statements and Exhibits. The filing does not contain specific financial figures or transaction details in the provided text, but it indicates a formal submission to the SEC.

Why It Matters

This filing signifies a formal disclosure by Innoviva, Inc. to the SEC, which may contain important updates for investors regarding the company's financial status or other material events.

Risk Assessment

Risk Level: low — The filing is a standard SEC form without immediate negative or positive financial implications presented in the excerpt.

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing by Innoviva, Inc.?

The 8-K filing serves as a Current Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934, and specifically includes items related to Regulation FD Disclosure and Financial Statements and Exhibits.

When was the earliest event reported in this filing?

The date of the earliest event reported is May 13, 2024.

In which state was Innoviva, Inc. incorporated?

Innoviva, Inc. was incorporated in Delaware.

What is the business address and phone number for Innoviva, Inc.?

The business address is 1350 Old Bayshore Highway, Suite 400, Burlingame, California 94010, and the phone number is (650) 238-9600.

What are the SIC and IRS numbers listed for Innoviva, Inc.?

The Standard Industrial Classification (SIC) code is 2834 (Pharmaceutical Preparations), and the IRS Employer Identification Number is 94-3265960.

Filing Stats: 559 words · 2 min read · ~2 pages · Grade level 11.2 · Accepted 2024-05-13 09:27:38

Key Financial Figures

Filing Documents

01. Regulation FD Disclosure

Item 7.01. Regulation FD Disclosure. On May 13, 2024, Innoviva, Inc. (the "Company") made available on its website a revised Company investor presentation. A copy of the presentation is attached hereto as Exhibit 99.1 and is incorporated by reference herein. The information included in this Current Report on Form 8-K that is furnished pursuant to this Item 7.01, including the information contained in Exhibit 99.1 hereto, shall not be deemed to be "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section or Sections 11 and 12(a)(2) of the Securities Act of 1933, as amended. In addition, the information included in this Current Report on Form 8-K that is furnished pursuant to this Item 7.01, including the information contained in Exhibit 99.1 hereto, shall not be incorporated by reference into any filing of the Company, whether made before or after the date hereof, regardless of any general incorporation language in such filing, unless expressly incorporated by specific reference into such filing.

01. Financial Statements and Exhibits

Item 9.01. Financial Statements and Exhibits. (d) Exhibits 99.1 Investor Presentation 104 Cover Page Interactive File (the cover page tags are embedded within the Inline XBRL document) - 2- SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. INNOVIVA, INC. Date: May 13, 2024 By: /s/ Pavel Raifeld Pavel Raifeld Chief Executive Officer -3-

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing